Skip to main content

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in NRIX — Nurix Therapeutics, Inc.

CIK 861177 NEW YORK, NY

Position in NRIX

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$3,277,620
+$838,696 QoQ
Shares Held
135,104
-14.1% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 210 holders
Holding Since
Jun 2021
19 quarters on record
Voting authority Sole 54% Shared 0% None 46%

Common Shares in NRIX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,385,897,555 across 206 Biotechnology names. NRIX ranks #81 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in NRIX

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,277,620 135,104
2026-03-31 $2,438,924 157,350
2025-12-31 $3,202,949 168,843
2025-09-30 $906,859 98,145
2025-06-30 $2,643,105 232,055
2025-03-31 $1,895,215 159,530
2024-12-31 $2,764,072 146,713
2024-09-30 $2,887,933 128,524
2024-06-30 $2,685,363 128,671
2023-09-30 $1,891,175 240,608
2023-06-30 $2,464,640 246,711
2023-03-31 $2,190,791 246,711
2022-12-31 $2,695,543 245,496
2022-09-30 $3,004,611 230,592
2022-06-30 $3,095,343 244,305
2022-03-31 $3,548,340 253,272
2021-12-31 $8,073,862 278,890
2021-09-30 $8,571,524 286,099
2021-06-30 $7,584,395 285,880